Restoring Immunity, Defeating Cancer

Rebooting Immunity, Restoring Health

At allevia, we tackle immunosenescence head-on, revitalizing the immune system to improve cancer and infectious disease outcomes.

50+

3+

Preclinical indications

Patents pending/granted

Our Mission

Precision R&D accelerating immune restoration for cancer and infectious diseases.

Pre-Clinical Assets

Robust proof-of-concept data underpinning scalable platforms targeting immunosenescence.

IP & Platforms

High-moat intellectual property powering multi-modality approaches to rejuvenate immunity.

Reach Out

Learn more about our immune restoration breakthroughs